These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4646813)

  • 1. Inhibition of 1- -D-arabinofuranosyl cytosine phosphorylation in human livers by tetrahydrouridine.
    Ho DH
    Biochem Pharmacol; 1972 Nov; 21(21):2936-40. PubMed ID: 4646813
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB; Saslaw LD; Waravdekar VS
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
    Plunkett W; Chubb S; Barlogie B
    J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
    Furner RL; Mellett LB; Herren TC
    J Pharmacol Exp Ther; 1975 Jul; 194(1):103-10. PubMed ID: 1057009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEEDBACK INHIBITION OF URIDINE KINASE BY CYTIDINE TRIPHOSPHATE AND URIDINE TRIPHOSPHATE.
    ANDERSON EP; BROCKMAN RW
    Biochim Biophys Acta; 1964 Nov; 91():380-6. PubMed ID: 14254009
    [No Abstract]   [Full Text] [Related]  

  • 7. Depression of thymidylate synthetase activity in response to cytosine arabinoside.
    Roberts D; Loehr EV
    Cancer Res; 1972 Jun; 32(6):1160-9. PubMed ID: 4503638
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of pancreatic ribonuclease A by arabinonucleotides.
    Pollard DR; Nagyvary J
    Biochemistry; 1973 Mar; 12(6):1063-6. PubMed ID: 4734659
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced uridine kinase and RNA synthesis in regenerating rat liver after 5-azacytidine administration.
    Cihàk A; Seifertovà M; Veselỳ J
    Arch Biochem Biophys; 1972 Feb; 148(2):400-6. PubMed ID: 5019867
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro.
    Kessel D; Hall TC; Rosenthal D
    Cancer Res; 1969 Feb; 29(2):459-63. PubMed ID: 5250069
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased conversion of uridine-5'-phosphate and uridine-5'-triphosphate to cytosine nucleotides by a liver fraction from colchicine-treated rats.
    Weinfeld H; Sandberg AA
    Biochem Pharmacol; 1967 Feb; 16(2):375-83. PubMed ID: 6029918
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man.
    Creasey WA; Papac RJ; Markiw ME; Calabresi P; Welch AD
    Biochem Pharmacol; 1966 Oct; 15(10):1417-28. PubMed ID: 4291357
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
    Konishi Y; Shinozuka H; Farber JL
    Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
    [No Abstract]   [Full Text] [Related]  

  • 14. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 15. mRNA turnover studies applying labeled uridine require an evaluation of specific radioactivities of UTP and RNA-U.
    Kramer G; Wiegers U; Hilz H
    Biochem Biophys Res Commun; 1973 Nov; 55(2):273-81. PubMed ID: 4767304
    [No Abstract]   [Full Text] [Related]  

  • 16. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR; Burchenal JH; Kreis W; Fox JJ
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
    Keppler DO; Smith DF
    Cancer Res; 1974 Apr; 34(4):705-11. PubMed ID: 4360835
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake and metabolism of exogenous uridine by superfused rat liver slices.
    Tseng JK; Gurpide E
    Biochim Biophys Acta; 1974 Jul; 353(4):399-406. PubMed ID: 4855329
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
    Ho DH
    Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.